deltatrials
Completed NCT00178997

Realistic Models of Gastrointestinal Bioelectromagnetism

Sponsor: Alan Bradshaw

Conditions Ischemia
Updated 7 times since 2017 Last updated: Apr 5, 2017 Started: Feb 29, 2004 Primary completion: Sep 1, 2010 Completion: Sep 1, 2010

Listed as NCT00178997, this observational or N/A phase trial focuses on Ischemia and remains completed. Sponsored by Alan Bradshaw, it has been updated 7 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

Show 2 earlier versions
  1. May 2017 — Apr 2018 [monthly]

    Completed NA

    Status: Unknown StatusCompleted · Phase: PHASE1NA

  2. Jan 2017 — May 2017 [monthly]

    Unknown Status PHASE1

    First recorded

Feb 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alan Bradshaw
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • Nashville, United States